Published in Hepatitis Weekly, November 6th, 2000
Researchers at Baylor University, Texas, recently described a timeline for individuals with HCV who are more likely to suffer organ rejection after liver transplant surgery. G. Gesta et al. noted in their report, "The time progression of allograft damage in patients with recurrent hepatitis C after orthotopic liver transplantation (OLT) is not precisely determined."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.